BrightSpring (NASDAQ: BTSG) executive exercises 35K options, sells 35K shares in offering

Rhea-AI Filing Summary

BrightSpring Health Services, Inc. executive Lisa A. Nalley exercised stock options and sold shares in a coordinated transaction. She exercised options to acquire 35,000 shares of common stock at $6.37 per share, then sold 35,000 shares in a registered public offering that closed on June 5, 2026 at $58.75 per share before underwriting discounts and commissions.

After these transactions, Nalley holds 131,948 shares of common stock directly and 41,909 stock options that remain outstanding and fully vested, expiring on September 24, 2029. The activity represents an exercise-and-sell pattern that converts part of her option position into cash while retaining a substantial equity stake.

Insights

Equity compensation and insider-trading analyst

Routine option exercise and sale tied to a public offering.

Lisa A. Nalley of BrightSpring Health Services exercised 35,000 stock options at $6.37 and sold 35,000 shares at $58.75 in a registered public offering that closed on June 5, 2026. This is a classic exercise-and-sell sequence.

The filing shows 131,948 common shares held directly after the sale and 41,909 stock options remaining, fully vested, expiring on September 24, 2029. Because a registered public offering is involved, the sale aligns with a broader capital markets transaction rather than isolated open-market activity.

The transaction converts part of Nalley’s option-based compensation into cash while keeping a sizable ongoing equity position. Given the scale relative to her remaining holdings and the offering context, this looks like routine liquidity management rather than a thesis-changing move for investors.

Insider Trade Summary

Net Seller: 35,000 shares ($2,056,250)

Net Sell 3 txns

Insider Nalley Lisa A

Role See Remarks

Sold 35,000 shs ($2.06M)

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy)	35,000	$0.00	--
Exercise	Common Stock	35,000	$6.37	$223K
Sale	Common Stock	35,000	$58.75	$2.06M

Holdings After Transaction: Stock Options (Right to Buy) — 41,909 shares (Direct, null); Common Stock — 166,948 shares (Direct, null)

Footnotes (1)

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions. These options are fully vested.

Key Figures

Shares sold: 35,000 shares Sale price: $58.75/share Options exercised: 35,000 options +4 more

7 metrics

Shares sold 35,000 shares Common stock sold in registered public offering at $58.75

Sale price $58.75/share Registered public offering closing price before underwriting discounts

Options exercised 35,000 options Stock options exercised into common stock

Option exercise price $6.37/share Strike price for exercised stock options

Shares owned after 131,948 shares Direct common stock holdings following transactions

Options remaining 41,909 options Fully vested stock options outstanding after exercise

Option expiration September 24, 2029 Expiration date of the remaining stock options

Key Terms

registered public offering, underwriting discounts and commissions, Stock Options (Right to Buy), Exercise or conversion of derivative security, +1 more

5 terms

registered public offering financial

"shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering"

A registered public offering is when a company files required documents with regulators to sell new shares or bonds to the general public, providing standardized financial and business information for transparency. For investors, it matters because it creates an opportunity to buy newly issued securities while often increasing market liquidity, but it can also dilute existing ownership and affect share price as supply and company funding needs change—think of a bakery baking extra loaves that can satisfy more customers but slightly reduces each owner's slice of the original batch.

underwriting discounts and commissions financial

"at a price of $58.75, before deducting underwriting discounts and commissions"

Underwriting discounts and commissions are fees paid to financial institutions that help sell new securities to investors. They act like a commission for their role in connecting companies with buyers, often reducing the amount of money the issuing company raises. For investors, understanding these costs helps gauge how much of their investment is going toward the actual securities versus fees paid to middlemen.

Stock Options (Right to Buy) financial

"security_title": "Stock Options (Right to Buy)""

Exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nalley Lisa A

(Last) (First) (Middle)

C/O BRIGHTSPRING HEALTH SERVICES, INC.

805 N. WHITTINGTON PARKWAY

(Street)

LOUISVILLE KENTUCKY 40222

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BrightSpring Health Services, Inc. [ BTSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		M		35,000	A	$6.37	166,948	D
Common Stock	06/05/2026		S(1)		35,000	D	$58.75(1)	131,948	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	$6.37	06/05/2026		M			35,000	(2)	09/24/2029	Common Stock	35,000	$0	41,909	D

Explanation of Responses:

1. These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions.

2. These options are fully vested.

Remarks:

Title: Chief of Staff and Senior Vice President, Human Resources

	/s/ Jennifer Phipps, as Attorney-in-Fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)